Literature DB >> 26106146

Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders.

Amy F T Arnsten1, Min Wang2, Constantinos D Paspalas2.   

Abstract

The prefrontal cortex (PFC) elaborates and differentiates in primates, and there is a corresponding elaboration in cortical dopamine (DA). DA cells that fire to both aversive and rewarding stimuli likely project to the dorsolateral PFC (dlPFC), signaling a salient event. Since 1979, we have known that DA has an essential influence on dlPFC working memory functions. DA has differing effects via D1 (D1R) versus D2 receptor (D2R) families. D1R are concentrated on dendritic spines, and D1/5R stimulation produces an inverted U-shaped dose response on visuospatial working memory performance and Delay cell firing, the neurons that generate representations of visual space. Optimal levels of D1R stimulation gate out "noise," whereas higher levels, e.g., during stress, suppress Delay cell firing. These effects likely involve hyperpolarization-activated cyclic nucleotide-gated channel opening, activation of GABA interneurons, and reduced glutamate release. Dysregulation of D1R has been related to cognitive deficits in schizophrenia, and there is a need for new, lower-affinity D1R agonists that may better mimic endogenous DA to enhance mental representations and improve cognition. In contrast to D1R, D2R are primarily localized on layer V pyramidal cell dendrites, and D2/3R stimulation speeds and magnifies the firing of Response cells, including Response Feedback cells. Altered firing of Feedback neurons may relate to positive symptoms in schizophrenia. Emerging research suggests that DA may have similar effects in the ventrolateral PFC and frontal eye fields. Research on the orbital PFC in monkeys is just beginning and could be a key area for future discoveries.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26106146      PMCID: PMC4485014          DOI: 10.1124/pr.115.010512

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  156 in total

Review 1.  Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Authors:  Amy F T Arnsten; Bao-Ming Li
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

2.  Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

Authors:  Susheel Vijayraghavan; Min Wang; Shari G Birnbaum; Graham V Williams; Amy F T Arnsten
Journal:  Nat Neurosci       Date:  2007-02-04       Impact factor: 24.884

3.  Neuronal activity related to saccadic eye movements in the monkey's dorsolateral prefrontal cortex.

Authors:  S Funahashi; C J Bruce; P S Goldman-Rakic
Journal:  J Neurophysiol       Date:  1991-06       Impact factor: 2.714

Review 4.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

Review 5.  Stress and the mesocorticolimbic dopamine systems.

Authors:  R H Roth; S Y Tam; Y Ida; J X Yang; A Y Deutch
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

Review 6.  Biochemical and genetic analyses of childhood attention deficit/hyperactivity disorder.

Authors:  Emrah Caylak
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-07-23       Impact factor: 3.568

7.  The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.

Authors:  F J Lee; Z B Pristupa; B J Ciliax; A I Levey; H B Niznik
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

Review 8.  Dopaminergic mechanisms in idiopathic and drug-induced psychoses.

Authors:  J A Lieberman; B J Kinon; A D Loebel
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

9.  Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.

Authors:  Noemí Santana; Guadalupe Mengod; Francesc Artigas
Journal:  Cereb Cortex       Date:  2008-08-09       Impact factor: 5.357

10.  Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

Authors:  A M Owen; M James; P N Leigh; B A Summers; C D Marsden; N P Quinn; K W Lange; T W Robbins
Journal:  Brain       Date:  1992-12       Impact factor: 13.501

View more
  54 in total

Review 1.  Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Authors:  Laura L Giacometti; Jacqueline M Barker
Journal:  Brain Res       Date:  2019-08-14       Impact factor: 3.252

2.  Early postnatal manganese exposure causes arousal dysregulation and lasting hypofunctioning of the prefrontal cortex catecholaminergic systems.

Authors:  Travis E Conley; Stephane A Beaudin; Stephen M Lasley; Casimir A Fornal; Jasenia Hartman; Walter Uribe; Tooba Khan; Barbara J Strupp; Donald R Smith
Journal:  J Neurochem       Date:  2020-01-10       Impact factor: 5.372

3.  Dcc haploinsufficiency regulates dopamine receptor expression across postnatal lifespan.

Authors:  Matthew Pokinko; Alanna Grant; Florence Shahabi; Yvan Dumont; Colleen Manitt; Cecilia Flores
Journal:  Neuroscience       Date:  2017-01-17       Impact factor: 3.590

4.  Dopamine D2L Receptor Is Required for Visual Discrimination and Reversal Learning.

Authors:  Makiko Morita; Yanyan Wang; Toshikuni Sasaoka; Kinya Okada; Minae Niwa; Akira Sawa; Takatoshi Hikida
Journal:  Mol Neuropsychiatry       Date:  2016-07-21

Review 5.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

Review 6.  Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective.

Authors:  John H Krystal; Alan Anticevic; Genevieve J Yang; George Dragoi; Naomi R Driesen; Xiao-Jing Wang; John D Murray
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

Review 7.  Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive Disorders.

Authors:  Amy F T Arnsten; Min Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

Review 8.  Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.

Authors:  Amy F T Arnsten; Ragy R Girgis; David L Gray; Richard B Mailman
Journal:  Biol Psychiatry       Date:  2016-01-18       Impact factor: 13.382

Review 9.  Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex.

Authors:  Bo Xing; Yan-Chun Li; Wen-Jun Gao
Journal:  Brain Res       Date:  2016-01-11       Impact factor: 3.252

10.  Effects of acute administration of the GABA(B) receptor agonist baclofen on behavioral flexibility in rats.

Authors:  B Sofia Beas; Barry Setlow; Jennifer L Bizon
Journal:  Psychopharmacology (Berl)       Date:  2016-06-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.